The Supreme Court Protects Access to the Abortion Pill Mifepristone—At Least for Now

The final word on whether mifepristone can stay on the market has yet to come.

Young tourists shout their opposition to anti-abortion activists from the plaza in front of the U.S. Supreme Court. Chip Somodevilla/Getty

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

In a major, if temporary, victory for abortion rights advocates, the Supreme Court on Friday granted the Biden administration’s emergency request to pause a lower court ruling challenging the FDA’s approval of the abortion pill mifepristone after a Texas judge suspended it earlier this month. The decision, the high court’s most consequential abortion ruling since overturning Roe v. Wade last summer, will maintain access to the drug, which for over two decades has been widely used because it allows people to obtain abortions safely, effectively, and in the privacy of their own homes.

On April 7, a Trump-appointed judge in Texas, Matthew Kacsmaryk, ruled that the FDA had wrongly approved mifepristone—an unprecedented decision by a federal judge attempting to single-handedly pull a medication from the market. Kacsmaryk’s reasoning relied not only on a shocking lack of science, but also on an outdated, Victorian-era law that prohibits the mailing of “every obscene, lewd, lascivious, indecent, filthy or vile article, matter, thing, device, or substance.” Prior to Kacsmaryk’s ruling, the law, known as the Comstock Act, hadn’t been enforced in half a century. But since the overturning of Roe, anti-abortion activists have seized on the law, named after 1800s anti-sex crusader Anthony Comstock, to reach its end game of destroying abortion access at the federal level. The Biden administration asked the Supreme Court to put the lower court’s ruling on hold while litigation continues: The same day that Kacsmaryk issued his ruling, a federal judge in Washington state issued a ruling, in a different case, upholding access to mifepristone. The manufacturers of the pill have also both sued to keep it on the market.

Friday’s ruling means that access to mifepristone will remain the same, likely for at least several months, while the Fifth Circuit—and, potentially, the Supreme Court—fully considers the government’s appeal of Kacsmaryk’s order. According to legal journalist Chris Geidner, any Supreme Court appeal wouldn’t be heard until next term, which begins in October.

Through the ruling comes as a critical victory for abortion advocates, as my colleague Madison Pauly noted, abortion opponents could still achieve their goal of ending abortion access with the next Republican president. “You would only need a week,” Joanna Grossman, a law professor at Southern Methodist University, told Pauly. Read more on how here.

This post has been updated.

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with The Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with The Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate